☆ 4.5 Article

T cell immunity in interstitial lung disease with non-small cell lung cancer patients

LUNG CANCER (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Critical Care Medicine

Clinical Outcomes of Immune Checkpoint Inhibitor Therapy in Patients With Advanced Non-small Cell Lung Cancer and Preexisting Interstitial Lung Diseases A Systematic Review and Meta-analysis

Meng Zhang et al.

Summary: Patients with non-small cell lung cancer (NSCLC) and preexisting interstitial lung disease (ILD) have favorable clinical outcomes when treated with immune checkpoint inhibitors (ICIs). However, the incidence of immune-related adverse events, particularly checkpoint inhibitor pneumonitis (CIP), is higher in these patients. Clinicians should exercise caution when using ICIs in patients with preexisting ILD.

CHEST (2022)

添加到收藏夹

Article Critical Care Medicine

Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

Ganesh Raghu et al.

Summary: This article provides updates on the guidelines for idiopathic pulmonary fibrosis (IPF) and addresses the progression of pulmonary fibrosis in patients with interstitial lung diseases (ILDs) other than IPF. The recommendations are based on consensus and systematic reviews, aiming to provide evidence-based guidance for clinicians.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

添加到收藏夹

Article Respiratory System

Risk of cancer incidence in patients with idiopathic pulmonary fibrosis: A nationwide cohort study

Hong Yeul Lee et al.

Summary: IPF is associated with an increased risk for cancer incidence, especially lung cancer. Healthcare providers should be aware of this risk when treating patients with IPF.

RESPIROLOGY (2021)

添加到收藏夹

Article Oncology

Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes

Aanika Balaji et al.

Summary: Steroid-refractory ICI-pneumonitis accounted for 18.5% of multidisciplinary irAE care referrals. This condition often occurred early in patients' treatment courses and most commonly presented with a diffuse alveolar damage (DAD) radiographic pattern. Patients treated with IVIG alone showed improvement in level-of-care and oxygenation requirements, with lower fatality rates (43%) compared to those treated with infliximab (100% mortality).

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

添加到收藏夹

Article Oncology

Success and failure of additional immune modulators in steroid-refractory/resistant pneumonitis related to immune checkpoint blockade

Jason Beattie et al.

Summary: Immune checkpoint blockade-related pneumonitis is rare but can have severe outcomes. This study found that additional immune modulators can provide durable improvement in patients who are refractory or resistant to steroids, highlighting the need for more precise and effective treatment strategies in the future.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

添加到收藏夹

Article Oncology

Non-inferior clinical outcomes of immune checkpoint inhibitors in non-small cell lung cancer patients with interstitial lung disease

Yuri Tasaka et al.

Summary: A study on the use of immune checkpoint inhibitors (ICIs) in non-small-cell lung cancer (NSCLC) patients found that while patients with pre-existing interstitial lung disease (ILD) were more prone to checkpoint inhibitor pneumonitis (CIP), their treatment outcomes and survival rates were not inferior to those without ILD.

LUNG CANCER (2021)

添加到收藏夹

Article Oncology

Association of immune-related pneumonitis with the presence of preexisting interstitial lung disease in patients with non-small lung cancer receiving anti-programmed cell death 1 antibody

Ryota Shibaki et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)

添加到收藏夹

Article Pharmacology & Pharmacy

Lung cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study in Greece

Argyris Tzouvelekis et al.

PULMONARY PHARMACOLOGY & THERAPEUTICS (2020)

添加到收藏夹

Article Immunology

Regulatory T Cells Limit Pneumococcus-Induced Exacerbation of Lung Fibrosis in Mice

Steffi Moye et al.

JOURNAL OF IMMUNOLOGY (2020)

添加到收藏夹

Article Oncology

Chronic immune checkpoint inhibitor pneumonitis

Jarushka Naidoo et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)

添加到收藏夹

Article Oncology

A Phase 2 Study of Atezolizumab for Pretreated NSCLC With Idiopathic Interstitial Pneumonitis

Satoshi Ikeda et al.

JOURNAL OF THORACIC ONCOLOGY (2020)

添加到收藏夹

Article Immunology

Immune-checkpoint profiles for T cells in bronchoalveolar lavage fluid of patients with immune-checkpoint inhibitor-related interstitial lung disease

Kunihiro Suzuki et al.

INTERNATIONAL IMMUNOLOGY (2020)

添加到收藏夹

Article Medicine, Research & Experimental

The alveolar immune cell landscape is dysregulated in checkpoint inhibitor pneumonitis

Karthik Suresh et al.

JOURNAL OF CLINICAL INVESTIGATION (2019)

添加到收藏夹

Article Respiratory System

Aberrant populations of circulating T follicular helper cells and regulatory B cells underlying idiopathic pulmonary fibrosis

Yuichiro Asai et al.

RESPIRATORY RESEARCH (2019)

添加到收藏夹

Article Oncology

Efficacy and safety of nivolumab in non-small cell lung cancer with preexisting interstitial lung disease

Osamu Kanai et al.

THORACIC CANCER (2018)

添加到收藏夹

Article Respiratory System

Lung cancer in connective tissue disease-associated interstitial lung disease: clinical features and impact on outcomes

Satoshi Watanabe et al.

JOURNAL OF THORACIC DISEASE (2018)

添加到收藏夹

Article Oncology

Characteristics, incidence, and risk factors of immune checkpoint inhibitor related pneumonitis in patients with non-small cell lung cancer

Jun Yeun Cho et al.

LUNG CANCER (2018)

添加到收藏夹

Article Oncology

Pre-existing pulmonary fibrosis is a risk factor for anti-PD-1-related pneumonitis in patients with non-small cell lung cancer: A retrospective analysis

Teppei Yamaguchi et al.

LUNG CANCER (2018)

添加到收藏夹

Article Respiratory System

Characteristics of lung cancer among patients with idiopathic pulmonary fibrosis and interstitial lung disease - analysis of institutional and population data

Joo Heung Yoon et al.

RESPIRATORY RESEARCH (2018)

添加到收藏夹

Article Oncology

Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy

Jarushka Naidoo et al.

JOURNAL OF CLINICAL ONCOLOGY (2017)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

A clinicopathological study of surgically resected lung cancer in patients with usual interstitial pneumonia

Yasutaka Watanabe et al.

RESPIRATORY MEDICINE (2017)

添加到收藏夹

Article Immunology

Transcriptional Landscape of Human Tissue Lymphocytes Unveils Uniqueness of Tumor-Infiltrating T Regulatory Cells

Marco De Simone et al.

IMMUNITY (2016)

添加到收藏夹

Article Immunology

Regulatory T Cells Exhibit Distinct Features in Human Breast Cancer

George Plitas et al.

IMMUNITY (2016)

添加到收藏夹

Article Critical Care Medicine

The Impact of Lung Cancer on Survival of Idiopathic Pulmonary Fibrosis

Sara Tomassetti et al.

CHEST (2015)

添加到收藏夹

Article Immunology

Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor

Makoto Miyara et al.

IMMUNITY (2009)

添加到收藏夹

Article Respiratory System

Cumulative incidence of and predictive factors for lung cancer in IPF

Yuichi Ozawa et al.

RESPIROLOGY (2009)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK

Ivan Le Jeune et al.

RESPIRATORY MEDICINE (2007)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.